FI953957A - 1,4-dihydropyridiini-3,5-dikarboksyylihappoestereiden käyttö lääkeaineena - Google Patents

1,4-dihydropyridiini-3,5-dikarboksyylihappoestereiden käyttö lääkeaineena Download PDF

Info

Publication number
FI953957A
FI953957A FI953957A FI953957A FI953957A FI 953957 A FI953957 A FI 953957A FI 953957 A FI953957 A FI 953957A FI 953957 A FI953957 A FI 953957A FI 953957 A FI953957 A FI 953957A
Authority
FI
Finland
Prior art keywords
dihydropyridine
drug
dicarboxylic acid
acid esters
esters
Prior art date
Application number
FI953957A
Other languages
English (en)
Swedish (sv)
Other versions
FI953957A0 (fi
Inventor
Klaus Urbahns
Otto Behner
Siegfried Goldmann
Hans-Georg Heine
Bodo Junge
Rudolf Schohe-Loop
Egbert Wehinger
Hartmund Wollweber
Henning Sommermeyer
Thomas Glaser
Reilinde Wittka
Vry Jean-Marie-Viktor De
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI953957A0 publication Critical patent/FI953957A0/fi
Publication of FI953957A publication Critical patent/FI953957A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI953957A 1994-08-25 1995-08-23 1,4-dihydropyridiini-3,5-dikarboksyylihappoestereiden käyttö lääkeaineena FI953957A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430094A DE4430094A1 (de) 1994-08-25 1994-08-25 Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel

Publications (2)

Publication Number Publication Date
FI953957A0 FI953957A0 (fi) 1995-08-23
FI953957A true FI953957A (fi) 1996-02-26

Family

ID=6526498

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953957A FI953957A (fi) 1994-08-25 1995-08-23 1,4-dihydropyridiini-3,5-dikarboksyylihappoestereiden käyttö lääkeaineena

Country Status (14)

Country Link
US (2) US5665741A (fi)
EP (1) EP0705819A1 (fi)
JP (1) JPH0859468A (fi)
KR (1) KR960007563A (fi)
CN (1) CN1128757A (fi)
AU (1) AU3011295A (fi)
CA (1) CA2156673A1 (fi)
DE (1) DE4430094A1 (fi)
EE (1) EE9500055A (fi)
FI (1) FI953957A (fi)
HU (1) HUT74617A (fi)
IL (1) IL115030A0 (fi)
NO (1) NO953322L (fi)
PL (1) PL310146A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5568200A (en) 1999-06-23 2001-01-09 Ajinomoto Co., Inc. Dihydropyridine derivative
EP1479397B1 (en) * 2002-02-05 2011-06-08 Astellas Pharma Inc. 2,4,6-triamino-1,3,5-triazine derivative
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
US10258498B2 (en) 2011-11-24 2019-04-16 Richter Gedeon Nyrt. 1,4-dihydropyridine derivatives with Hsp modulating activity
CN104710441B (zh) * 2014-12-18 2017-01-18 苏州科技学院 吡啶五甲酸二钾化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
US3883543A (en) * 1969-05-10 1975-05-13 Bayer Ag N-alkyl-1,4-dihydropyridines
JPS4899181A (fi) * 1972-04-04 1973-12-15
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
EP0287828A1 (de) * 1987-03-27 1988-10-26 Byk Gulden Lomberg Chemische Fabrik GmbH Neue Zwischenprodukte und Verfahren
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NO953322D0 (no) 1995-08-24
US5955482A (en) 1999-09-21
CA2156673A1 (en) 1996-02-26
CN1128757A (zh) 1996-08-14
AU3011295A (en) 1996-03-07
IL115030A0 (en) 1995-12-08
EE9500055A (et) 1996-04-15
JPH0859468A (ja) 1996-03-05
NO953322L (no) 1996-02-26
FI953957A0 (fi) 1995-08-23
HU9502509D0 (en) 1995-10-30
DE4430094A1 (de) 1996-02-29
PL310146A1 (en) 1996-03-04
HUT74617A (en) 1997-01-28
EP0705819A1 (de) 1996-04-10
US5665741A (en) 1997-09-09
KR960007563A (ko) 1996-03-22

Similar Documents

Publication Publication Date Title
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
FI871492A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi
DE69531834D1 (de) Herstellung einer aerosolformulierung von insulin
FR12C0053I2 (fr) Dihydropyridines a activite courte
FI954007A0 (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
NL192832B (nl) 1,8 gebrugde 6-halogeen-4-chinolon-3-carbonzuurderivaten en farmaceutisch preparaat dat een dergelijk derivaat bevat.
NO951147D0 (no) Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel
FI953957A (fi) 1,4-dihydropyridiini-3,5-dikarboksyylihappoestereiden käyttö lääkeaineena
FI941149A0 (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
NO960777D0 (no) Anvendelse av N-alkylerte 1,4-dihydropyridin dikarboksylsyreestere som medikamenter
NO307704B1 (no) 8-trifluormetylkinolinkarboksylsyre-derivat, medisinsk preparat inneholdende derivatet, samt anvendelse av et medisinsk preparat
ZA93210B (en) Specific 1,4-dihydropyridine-3, 5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use.
DE69419674D1 (de) Optisch aktive 1,4-Dihydropyridinderivate und Verfahren zu ihrer Herstellung
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler
DE69609219D1 (de) Peroxycarbonsäureester Photoinitiatoren abgeleitet von Stickstoff-Heterozyklen
DE69817868D1 (de) 4-fluoro-3-oxocarbonsäureester und ihre herstellung
DE69305250D1 (de) Herstellung von Alkandicarbonsäurederivaten
DK142287D0 (da) Optisk aktive 1,4-dihydropyridinderivater
KR950702115A (ko) 디히드로피리딘 유도체의 신규 의약 용도(novel medicinal use of dihydropyridine derivative)
DE59504642D1 (de) Herstellung von carbaminsäurevinylestern
DE69527684D1 (de) Herstellung von 3-oxy-5-oxo-6-Heptensäurederivaten
DE69502982D1 (de) Herstellung geschützter Aminothiazolylessigsäurederivate
ZA935191B (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use.
DE69614716D1 (de) Dihydrat von (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionsäure ester von 4,10-beta-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa(g]tax-11-en-13alpha-yl und verfahren zu ihrer herstellung
DE59606925D1 (de) 1,6-Naphthyridoncarbonsäurederivate